AstraZeneca PLC Says FDA Requests Seroquel Information

LONDON, Dec 24 (Reuters) - AstraZeneca said the U.S. Food and Drug Administration (FDA) had requested further information relating to a supplemental new drug application for its schizophrenia drug Seroquel.